Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 50013033
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 480nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.53E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (Standard transfer reaction)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 7.00E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 8.50E+4nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda
Curated by ChEMBL
National Cancer Institute-Bethesda
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory concentration against Recombinant HIV-1 integrase (3'processing)More data for this Ligand-Target Pair











